Astellas confirms FSP alliance with INC Research
This article was originally published in Scrip
Astellas has entered into a three-year functional service provider (FSP) alliance, an outsourcing model that packages together similar tasks functionally across an entire clinical development programme, with INC Research, to save time and reduce costs in multiple clinical portfolios.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"